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Abstract 
Malaria is one of the most severe public health problems worldwide. It is a leading cause of death 
and disease in many developing countries, where young children and pregnant women are the 
groups most affected. Malaria disease caused by Plasmodium parasite have symptoms that 
typically include fever, fatigue, vomiting and headaches. In severe cases, it can cause yellow 
skin, seizures, coma or death. The present study is aimed to monitoring parasitemia level and 
percentage of parasite morphology as parasitaemia progresses. This research used Plasmodium 
berghei NK strain obtained from National University of Malaysia which originally from MR4, USA. 
Design used in this research was completely randomized design, with 2 treatments which were 
mice without infection and mice with infection of P. berghei parasite. Method used in this research 
was staining method of thin smear of blood using Giemsa stained and observed by microscopic. 
Parameter of observation were morphology and development of P. berghei at different level of 
parasitaemia (10%, 20%, 30% and 40%). The result showed from microscopic examination of 
blood slides prepared from the study animals indicated that the ring form was dominant stage 
obtained at all different stages of infection followed by trophozoite stage. Meanwhile schizont 
stage was the lowest stage obtained at all different stages observed.  
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Introduction 
Malaria is a deadly disease that can lead to death (Philips, 2001; WHO, 2004). Children and pregnant 
women are the most vulnerable group of victims (CDC 2004). The disease is caused by infection with 
protozoan parasites of the genus Plasmodium (Carvalho et al., 2007). The World Health Organization 
(WHO) has reported about 4 billion people from 90 different countries are at risk of contracting the 
disease and as many as 500 million cases of malaria are reported each year (Carvalho et al., 2007; 
Esmark et al. 2006), and the death of at least 1 up to 2.5 million people each year (Curtidor et al., 
2006; Esmark et al., 2006; WHO, 2009). 
 
Most of deaths occurred in south Africa of the Sahara desert that is 80 percent of the total deaths 
from malaria worldwide (Pettersson 2005). In children, death is usually caused by cerebral malaria, 
acute anemia and respiratory disorders, meanwhile deaths in adults other than respiratory distress 
syndrome, the symptoms are more prevalent such as kidney damage and lung damage ( Becker et al. 
2004). In addition, the disease can cause an enlarged spleen and liver (Engwerda et al. 2004). This 
condition is caused by a buildup of malaria pigment granules. Plasmodium that attack small mammals 
such as mice among which are P. berghei (Cruz et al. 2000; Lau et al. 2001; Sherman 1998). 
Plasmodium has been used in studies to replace the use of P. falciparum in many aspects such as drug 
resistance, the diversity of antigens, the mechanisms of entry into the erythrocyte and study of 
organelles plastids. The results of an assessment of the rodent parasite and the host is very helpful in 
assessing the relationship between Plasmodium in human (Leiden University, 2005).Intraeritrosit 
stage is the most violent stage of infection (Menard, 2000; Vaid, 2007). Merozoites are released from 
the infected erythrocyte will be in plasma and bind erythrocyte and entering new ones. In circulation, 
merozoites quickly attaches and enters erythrocytes and replicate to produce new infective merozoites 
(Cowman and Crabb, 2006). This cycle continues until create clinical symptoms in patients 
(Greenwood et al. 2005). The transition stage in different cells and tissues in the mosquito vector and 
the mammalian host shows a high ability of malaria parasite to adapt to its environment 
(Matuschewski 2006; Vaughan et al., 2008). Merozoites are released into the bloodstream to infect 
erythrocytes either repeat the cycle intraeritrosit through the establishment of schizont-merozoites, or 
undergo a gametogenesis process for the formation of gametocytes (Bannister & Mitchell, 2003; 
Fujiako and Aikawa, 1999). 
 
Materials and Methods 
The study began with the isolation and preservation of in vivo culture parasite P. berghei in mice 
stocks and make infection in mice with a predetermined dose of 1 x 106 infected erythrocytes/ mice. 
The research was conducted at the Laboratory of Microtechnique, FMIPA, Unsyiah. The materials used 
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in this study are the cryopreservation of parasite Plasmodium berghei, methanol, Giemsa dye and 
physiologycal saline solution.  
 
Inoculation of P. berghei Parasite  
White male mice Balb / c for about 8 weeks old were distributed in two treatments, the mice without 
infection with P. berghei-infected mice as controls and P. berghei infected mice.  
Furthermore, P. berghei-infected mice were divided into 4 groups of sampling at 10% parasitemia, 
20% parasitemia, 30% parasitaemia and 40% parasitaemia. Each sampling involves 5 mice. 
 
P. berghei which cryopreserved in liquid of nitrogen first heated in the bath 37 ° C for 10 minutes. 
Furthermore, the solution containing the parasite is mixed with NaCl NaCl physiological saline solution 
in the ratio 1: 1 and centrifuged for 10 minutes at speeds of 650 x g. Pellets composed of P. berghei-
infected erythrocytes then mixed again with physiological NaCl in the ratio of 1: 1. The pellets are 
then injected in healthy mice as stocks by intraperitoneal route.  P. berghei inoculums are then 
prepared from stock mice which have parasitemia about 30%. The number of erythrocytes calculated 
using Haemasitometer and level of parasitaemia observed throughout thin blood smear of slide with 
Giemsa staining (Field & Shute 1955). Furthermore, parasitic blood was taken from the tail end of a 
small piece of mice stock and diluted with physiological saline solution at the dose of 1 x 106 
erythrocytes infected with malaria parasites/mice and then injected into mice in each treatment. 
 
Giemsa staining  
Thin blood smear of slide treated and control mice were stained by Giemsa. Before stained, slides 
were fixed with methanol and allowed to dry for 1 minute in room temperature. After that, slide 
colored with Giemsa dye which diluted in a volume of  1: 9 with a phosphate buffer solution (PBS), pH 
6.8, and left for 20 to 30 minutes. The slide is then washed with tap water flows slowly and dried at 
room temperature. The percentage of parasitaemia observed further under the light microscope with 
100x magnification. 
 
Determination of Parasitemia Level 
A drop of infected blood of mice were obtained aseptically from the tail end of mice and smeared on 
sterile glass objects. Thin blood smear of slide then stained by Giemsa and observed under a light 
microscope with a magnification of 100 times. Parasitaemia level calculated by the formula of Hauda 
et.al (1993) as follows: 
 
Results and Discussion 
Monitoring of the development of parasitaemia in the infected mice was done after inoculation of 
parasite P. berghei. Treated mice that have reached percentage of parasitaemia at 10%, 20%, 30% 
and 40% was monitored by making thin blood smear of slide as mentioned above. The morphology of 
the parasite at every stage parasitaemia was also monitored in each group of animals. Figures and 
tables below showed the morphological forms of ring and trophozoite stages  of  P. berghei.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10% Parasitemia 20% Parasitemia 
30% Parasitemia 40% Parasitemia 
Figure 1.  Morphology of intraerythrocyte P. berghei parasite at 10%, 20%, 30% and 
40% parasitaemia which observed using light microscope at 100 x 
magnification. 
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Table 1. Percentage of P. berghei morphology in infected erythrocyte (%) 
 
Parasitaemia (%) 
Morphology of P. berghei in infected erythrocyte (%) 
Ring form (n=5) Trophozoite (n=5) Schyzon (n=5) 
10 72.15 + 2.11 24.26 + 2.10 0.34 + 0.17 
20 55.72 + 2.34 40.37 + 2.15 0.50 + 0.22 
30 54.76 + 2.45 40.23 + 3.05 1.05 + 0.45 
40 53.18 + 3.22 44.56 + 3.45 0.29 + 0.12 
 
Both of these stages were always present highest at every level of parasitaemia, while the schizont 
stage was the lowest stage presents  and only can be detected less than 1% of all group of parasitic 
morphology. The lowest level of intraeritrosit schizont stage was thought to occured because the 
parasite-infected erythrocytes have been lost at this stage in the blood circulation system and then 
gathered in organ capillaries such as the lungs, liver and spleen to undergo the process of 
intraeritrosit schyzogoni (Jansen & Waters, 2002). The release of merozoites in schizont stage causing 
the attendance of early stage of infection which is a ring and trophozoite forms in erythrocytes. Most 
of the parasite infected erythrocytes containing ring form that is 53-73% and 23-44% of trophozoite 
form. The presence of more ring forms at the 10% level of parasitaemia compared with 20% to 40% 
parasitaemia was also thought to be an early-phase release of merozoites in erythrocytes infected by 
P. berghei parasites. This process resulted in the presence of more rings and young trophozoites stage 
were observed in thin smear of blood on each level of parasitaemia. 
 
Conclusions 
The development of parasitaemia in the infected mice observed from microscopic examination of blood 
slides prepared from the study animals indicated that the ring form was dominant stage obtained at all 
different stages of infection followed by trophozoite stage. Meanwhile schizont stage was the lowest 
stage obtained at all different stages observed.  
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